Editorial Board

Editors-in-Chief

Primo Nery Lara

Primo N. Lara, Jr., MD
University of California Davis Comprehensive Cancer Center
Sacramento, CA, USA
Email: kca@iospress.com

 

Peter Mulder

Peter Mulders, MD, PhD
Radboud UMC
Nijmegen, The Netherlands
Email: kca@iospress.com

Associate Editors

Axel Bex, MD, PhD
Netherlands Cancer Institute, Amsterdam, The Netherlands

Toni K. Choueiri, MD
Dana-Farber Cancer Institute, Boston, USA

Viktor Grünwald, MD
Medical School Hannover (MHH), Hannover, Germany

Lauren C. Harshman, MD
Dana-Farber Cancer Institute, Boston, USA

Eric Jonasch, MD
The University of Texas MD Anderson Cancer Center, Houston, USA

Bradley C. Leibovich, MD
Mayo Clinic, Rochester, USA

Egbert Oosterwijk, PhD
Radboud UMC, Nijmegen, The Netherlands

Hirotsugu Uemura, MD, PhD
Kindai University Faculty of Medicine, Osaka, Japan

Javier Puente, MD, PhD
Hospital Clinico Universitario San Carlos, Madrid, Spain

Christopher G. Wood, MD
The University of Texas MD Anderson Cancer Center, Houston, USA

Social Media Editor

Axel S. Merseburger, MD, PhD
University Hospital Schleswig-Holstein, Lübeck, Germany

Associate Editors for Reviews 

Stephane Oudard, MD, PhD
Hôpital Européen Georges Pompidou, Paris, France

Sumanta Pal, MD
City of Hope, Duarte, USA

Editor of Clinical Trials Corner 

Thomas Powles, MD
The Royal Free NHS Trust and Barts Cancer Institute, London, United Kingdom

 

Editorial Board 

Hideyuki Akaza, MD
University of Tokyo, Tokyo, Japan

Georg A. Bjarnason, MD, FRCP(C)
Sunnybrook Odette Cancer Center, Toronto, Canada

William P. Bro
Kidney Cancer Association, Chicago, USA

James Brugarolas, MD, PhD
University of Texas Southwestern Medical Center, Dallas, USA

Ronald M. Bukowski, MD
Cleveland Clinic Foundation, Cleveland, USA

Steven C. Campbell, MD, PhD
Cleveland Clinic, Cleveland, USA

Marc Dall’era, MD
UC Davis Comprehensive Cancer Center, Sacramento, USA

Tanya B. Dorff, MD 
City of Hope, Duarte, USA

Janice P. Dutcher, MD
Cancer Research Foundation, Chappaqua, USA

Tim Eisen, PhD
University of Cambridge, Cambridge, United Kingdom

Bernard Escudier, MD
Institut Gustave Roussy, Villejuif, France

Robert A. Figlin, MD
Cedars-Sinai Medical Center, Los Angeles, USA

Thomas (Tom) Flaig, MD
University of Colorado School of Medicine, Aurora, USA

Jorge Garcia, MD
Cleveland Clinic, Cleveland, USA

Dan George, MD
Duke University School of Medicine, Durham, USA

Martin Gore, PhD
The Royal Marsden Hospital and Instuitute of Cancer Research, London, United Kingdom

John Haanen, MD, PhD
Netherlands Cancer Institute, Amsterdam, The Netherlands

Naomi Haas, MD
University of Pennsylvania, Philadelphia, USA

Hans Hammers, MD, PhD
University of Texas Southwestern, Dallas, USA

Michael R. Harrison, MD
Duke Cancer Institute, Durham, USA

Daniel Heng, MD, MPH
Tom Baker Cancer Center, Calgary, Canada

Michelle S. Hirsch, MD, PhD
Brigham and Women's Hospital, Harvard Medical School, Boston, USA

James J. Hsieh, MD, PhD
Washington University School of Medicine, St. Louis, USA

Thomas Hutson, DO, PharmD
US Oncology/Baylor, Houston, USA

Choung Soo Kim, MD, PhD
Asan Medical Center, Seoul, South Korea

Won Kim, MD
University of California San Francisco, San Francisco, USA

Christian Kollmannsberger, MD
BC Cancer Agency, Vancouver, Canada

James Larkin, MD, PhD
The Institute of Cancer Research, London, United Kingdom

Marston Linehan, MD
National Cancer Institute, Bethesda, USA

Borje Ljungberg, MD, PhD
Umeå University, Umeå, Sweden

Susanne Osanto, MD, PhD
Leiden University Medical Center, Leiden, The Netherlands

Allan J. Pantuck, MD
UCLA Institute of Urologic Oncology, Los Angeles, USA

Mamta Parikh, MD
University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA

Elizabeth Plimack, MD
Fox Chase Cancer Center, Philadelphia, USA

Camillo Porta, MD
IRCCS San Matteo University Hospital Foundation, Pavia, Italy

David I. Quinn, MBBS, PhD
University of Southern California Norris Comprehensive Cancer Center, Los Angeles, USA

W. Kimryn (Kim) Rathmell, MD, PhD
Vanderbilt-Ingram Cancer Center, Nashville, USA

Bruce G. Redman, MD
University of Michigan, Ann Arbor, USA

Brian Rini, MD
Cleveland Clinic, Cleveland, USA

Paul Russo, MD
Memorial Sloan Kettering Cancer Center, New York, USA

Christopher Ryan, MD
Oregon Health Science University, Portland, USA

Manuela Schmidinger, MD
University of Austria, Vienna, Austria

Brian Shuch, MD
Yale School of Medicine/Smilow Cancer Center, New Haven, USA

Sandy Srinivas, MD
Stanford University, Stanford, USA

Ramaprasad Srinivasan, MD, PhD
National Cancer Institute, Bethesda, USA

Walter Stadler, MD
University of Chicago, Chicago, USA

Mark Stein, MD
Rutgers, The State University of New Jersey, New Brunswick, USA

Cora N. Sternberg, MD
San Camillo and Forlanini Hospitals, Rome, Italy

Cezary Szczylik, MD, PhD
Oncology Military Medical Institute, Warsaw, Poland

Nizar M. Tannir, MD
MD Anderson Cancer Center, Houston, USA

Ilya Tsimafeyeu, MD
Kidney Cancer Research Bureau, Russian Society of Clinical Oncology, Moscow, Russia

Robert G. Uzzo, MD
Fox Chase Cancer Center, Philadelphia, USA

Ulka Vaishampayan, MD
Wayne State University, Karmanos Cancer Institute, Detroit, USA

Guillermo de Velasco, MD, PhD
Hospital Universitario 12 de Octubre, Madrid, Spain

Nicholas J. Vogelzang, MD
Comprehensive Cancer Centers of Nevada (CCCN), Las Vegas, USA

Martin H. Voss, MD
Memorial Sloan Kettering Cancer Center, New York, USA

Stenio Zequi, MD, PhD
AC Camargo Cancer Center, Sao Paulo, Brazil